Analystreport

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) had its "outperform" rating re-affirmed by analysts at FBR & Co. They now have a $3.00 price target on the stock.

AVEO Pharmaceuticals, Inc.  (AVEO) 
Last aveo pharmaceuticals, inc. earnings: 3/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.aveooncology.com